Pioneer Group has announced an investment in Béa Fertility to further expand the company’s at-home fertility treatment programme. Proceeds will be used to fuel growth in the UK market and achieve FDA clearance ahead of US commercialisation. The Béa Treatment Programme starts with a 5-minute Online Medical Consultation. Once suitability is assessed, the Béa Treatment Programme commences with an at-home Intracervical Insemination…
Inito, the India-based health tech startup founded by Aayush Rai and Varun AV in 2015, has secured $6M in Series A funding led by Fireside Ventures. The fresh funds will go towards global expansion of Inito’s hormone testing solutions and will bolster research and development efforts for new diagnostic tests. Inito’s fertility monitor enables women to track fertility hormones quickly and conveniently…
A recent survey by Ferring Pharmaceuticals has brought to light the extensive struggles couples in Asia face on their fertility journey. The survey, covering seven Asian markets including India, highlights the long and emotional path to conception, often compounded by a lack of knowledge and emotional support. Long Journey to Parenthood The average duration from the decision to conceive to successful conception…
Cercle, an AI technology company, announced the launch of its platform, the Cercle Biomedical Graph. This technology aims to enhance women’s healthcare by connecting biomedical and genomics data points from healthcare clinics and research labs globally. The platform is designed to offer data insights that could improve medical care and research in the field of women’s health. The Cercle Biomedical Graph is…
Pollin Fertility, a Canadian fertility clinic and technology firm, has announced a $20M Series A fundraising round, led by Osmington. Set to open its doors on October 16 in Toronto’s Yonge and Eglinton district, Pollin Fertility, under the leadership of renowned fertility physician Dr. Kim Garbedian, aims to revolutionize fertility care in Canada with advanced technology and a state-of-the-art lab geared towards…
Women’s and Men’s Reproductive Health Pharma Company Besins Healthcare, has opened a new hormone production facility in Muel, Spain, bolsteing their global hormone production capacity by a 30%. This milestone is a response to the growing worldwide demand for hormones, particularly concerning late pregnancies and menopause. The opening follows Besins Healthcare’s strategic acquisition of a hormone production site in Drogenbos, Belgium, in…
Notify Therapeutics, a biotech company based in Denmark, has raised €5M in funding to advance the development of its innovative non-hormonal fertility treatment. The investment was made by Lundbeckfonden BioCapital and +ND Capital, highlighting their continued commitment to boosting Danish biotech and addressing pressing fertility issues. Founded from research by Professor Karin Lykke-Hartmann into female infertility, Notify Therapeutics is at the forefront…
A recent study published in the Nature demonstrates the potential of CHLOE, an AI decision support technology developed by Fairtility, to advance academic research in reproductive health. The study led by Professor Iris Har Vardi, an authority in the field of fertility and IVF, specifically focused on the impact of blastocyst morphometric parameters on implantation potential. Professor Har Vardi, Director of Fertility…
